Whole exome sequencing identifies FANCM as a susceptibility gene for estrogen-receptor-negative breast cancer in Hispanic/Latina women

Abstract Breast cancer (BC) is one of the most common cancers globally. Genetic testing facilitates screening and informs targeted risk-reduction and treatments. However, genes included in testing panels are from European-ancestry studies. We conducted a pooled case-control analysis in self-identifi...

Full description

Saved in:
Bibliographic Details
Main Authors: Jovia L. Nierenberg, Aaron W. Adamson, Donglei Hu, Scott Huntsman, Carmina Patrick, Min Li, Linda Steele, Shu Tao, Yuan Chun Ding, Barry Tong, Yiwey Shieh, Laura Fejerman, Stephen B. Gruber, Christopher A. Haiman, Esther M. John, Lawrence H. Kushi, Gabriela Torres-Mejía, Charité Ricker, Jeffrey N. Weitzel, Elad Ziv, Susan L. Neuhausen
Format: Article
Language:English
Published: Nature Portfolio 2025-08-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-025-60564-0
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849226112158138368
author Jovia L. Nierenberg
Aaron W. Adamson
Donglei Hu
Scott Huntsman
Carmina Patrick
Min Li
Linda Steele
Shu Tao
Yuan Chun Ding
Barry Tong
Yiwey Shieh
Laura Fejerman
Stephen B. Gruber
Christopher A. Haiman
Esther M. John
Lawrence H. Kushi
Gabriela Torres-Mejía
Charité Ricker
Jeffrey N. Weitzel
Elad Ziv
Susan L. Neuhausen
author_facet Jovia L. Nierenberg
Aaron W. Adamson
Donglei Hu
Scott Huntsman
Carmina Patrick
Min Li
Linda Steele
Shu Tao
Yuan Chun Ding
Barry Tong
Yiwey Shieh
Laura Fejerman
Stephen B. Gruber
Christopher A. Haiman
Esther M. John
Lawrence H. Kushi
Gabriela Torres-Mejía
Charité Ricker
Jeffrey N. Weitzel
Elad Ziv
Susan L. Neuhausen
author_sort Jovia L. Nierenberg
collection DOAJ
description Abstract Breast cancer (BC) is one of the most common cancers globally. Genetic testing facilitates screening and informs targeted risk-reduction and treatments. However, genes included in testing panels are from European-ancestry studies. We conducted a pooled case-control analysis in self-identified Hispanic/Latina women (4178 cases and 4344 controls), using whole exome sequencing and a targeted panel. We tested the association of loss of function (LoF) variants with overall, estrogen receptor (ER)-positive, and ER-negative BC risk. Using logistic regression, we found a strong association of LoF variants in FANCM with ER-negative BC (p = 4.1 × 10− 7), odds ratio [confidence interval]: 6.7 [2.9–15.6]). Among known susceptibility genes, BRCA1, BRCA2, and PALB2 strongly associated with BC. FANCM was previously proposed as a possible susceptibility gene for ER-negative BC, but is not routinely tested clinically. Our results demonstrate that FANCM should be added to BC gene panels.
format Article
id doaj-art-0d05aa45e8a94fe5a97f207f9fec6a91
institution Kabale University
issn 2041-1723
language English
publishDate 2025-08-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj-art-0d05aa45e8a94fe5a97f207f9fec6a912025-08-24T11:36:43ZengNature PortfolioNature Communications2041-17232025-08-011611910.1038/s41467-025-60564-0Whole exome sequencing identifies FANCM as a susceptibility gene for estrogen-receptor-negative breast cancer in Hispanic/Latina womenJovia L. Nierenberg0Aaron W. Adamson1Donglei Hu2Scott Huntsman3Carmina Patrick4Min Li5Linda Steele6Shu Tao7Yuan Chun Ding8Barry Tong9Yiwey Shieh10Laura Fejerman11Stephen B. Gruber12Christopher A. Haiman13Esther M. John14Lawrence H. Kushi15Gabriela Torres-Mejía16Charité Ricker17Jeffrey N. Weitzel18Elad Ziv19Susan L. Neuhausen20Department of Epidemiology and Biostatistics, University of California, San FranciscoDepartment of Population Sciences, Beckman Research Institute of City of HopeDepartment of Medicine, University of California, San FranciscoDepartment of Medicine, University of California, San FranciscoDepartment of Population Sciences, Beckman Research Institute of City of HopeDepartment of Medicine, University of California, San FranciscoDepartment of Population Sciences, Beckman Research Institute of City of HopeIntegrative Genomics Shared Resource, Beckman Research Institute of City of HopeDepartment of Population Sciences, Beckman Research Institute of City of HopeDepartment of Medicine, University of California, San FranciscoDepartment of Population Health Sciences, Weill Cornell MedicineDepartment of Public Health Service, University of California, DavisDepartment of Medical Oncology and Center for Precision Medicine, City of Hope National Medical CenterDepartment of Preventive Medicine, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern CaliforniaDepartment of Epidemiology & Population Health, Stanford University School of MedicineDivision of Research, Kaiser Permanente Northern CaliforniaInstituto Nacional de Salud PúblicaDepartment of Medicine, Keck School of Medicine, University of Southern CaliforniaDivision of Precision Prevention, The University of Kansas Comprehensive Cancer CenterDepartment of Medicine, University of California, San FranciscoDepartment of Population Sciences, Beckman Research Institute of City of HopeAbstract Breast cancer (BC) is one of the most common cancers globally. Genetic testing facilitates screening and informs targeted risk-reduction and treatments. However, genes included in testing panels are from European-ancestry studies. We conducted a pooled case-control analysis in self-identified Hispanic/Latina women (4178 cases and 4344 controls), using whole exome sequencing and a targeted panel. We tested the association of loss of function (LoF) variants with overall, estrogen receptor (ER)-positive, and ER-negative BC risk. Using logistic regression, we found a strong association of LoF variants in FANCM with ER-negative BC (p = 4.1 × 10− 7), odds ratio [confidence interval]: 6.7 [2.9–15.6]). Among known susceptibility genes, BRCA1, BRCA2, and PALB2 strongly associated with BC. FANCM was previously proposed as a possible susceptibility gene for ER-negative BC, but is not routinely tested clinically. Our results demonstrate that FANCM should be added to BC gene panels.https://doi.org/10.1038/s41467-025-60564-0
spellingShingle Jovia L. Nierenberg
Aaron W. Adamson
Donglei Hu
Scott Huntsman
Carmina Patrick
Min Li
Linda Steele
Shu Tao
Yuan Chun Ding
Barry Tong
Yiwey Shieh
Laura Fejerman
Stephen B. Gruber
Christopher A. Haiman
Esther M. John
Lawrence H. Kushi
Gabriela Torres-Mejía
Charité Ricker
Jeffrey N. Weitzel
Elad Ziv
Susan L. Neuhausen
Whole exome sequencing identifies FANCM as a susceptibility gene for estrogen-receptor-negative breast cancer in Hispanic/Latina women
Nature Communications
title Whole exome sequencing identifies FANCM as a susceptibility gene for estrogen-receptor-negative breast cancer in Hispanic/Latina women
title_full Whole exome sequencing identifies FANCM as a susceptibility gene for estrogen-receptor-negative breast cancer in Hispanic/Latina women
title_fullStr Whole exome sequencing identifies FANCM as a susceptibility gene for estrogen-receptor-negative breast cancer in Hispanic/Latina women
title_full_unstemmed Whole exome sequencing identifies FANCM as a susceptibility gene for estrogen-receptor-negative breast cancer in Hispanic/Latina women
title_short Whole exome sequencing identifies FANCM as a susceptibility gene for estrogen-receptor-negative breast cancer in Hispanic/Latina women
title_sort whole exome sequencing identifies fancm as a susceptibility gene for estrogen receptor negative breast cancer in hispanic latina women
url https://doi.org/10.1038/s41467-025-60564-0
work_keys_str_mv AT jovialnierenberg wholeexomesequencingidentifiesfancmasasusceptibilitygeneforestrogenreceptornegativebreastcancerinhispaniclatinawomen
AT aaronwadamson wholeexomesequencingidentifiesfancmasasusceptibilitygeneforestrogenreceptornegativebreastcancerinhispaniclatinawomen
AT dongleihu wholeexomesequencingidentifiesfancmasasusceptibilitygeneforestrogenreceptornegativebreastcancerinhispaniclatinawomen
AT scotthuntsman wholeexomesequencingidentifiesfancmasasusceptibilitygeneforestrogenreceptornegativebreastcancerinhispaniclatinawomen
AT carminapatrick wholeexomesequencingidentifiesfancmasasusceptibilitygeneforestrogenreceptornegativebreastcancerinhispaniclatinawomen
AT minli wholeexomesequencingidentifiesfancmasasusceptibilitygeneforestrogenreceptornegativebreastcancerinhispaniclatinawomen
AT lindasteele wholeexomesequencingidentifiesfancmasasusceptibilitygeneforestrogenreceptornegativebreastcancerinhispaniclatinawomen
AT shutao wholeexomesequencingidentifiesfancmasasusceptibilitygeneforestrogenreceptornegativebreastcancerinhispaniclatinawomen
AT yuanchunding wholeexomesequencingidentifiesfancmasasusceptibilitygeneforestrogenreceptornegativebreastcancerinhispaniclatinawomen
AT barrytong wholeexomesequencingidentifiesfancmasasusceptibilitygeneforestrogenreceptornegativebreastcancerinhispaniclatinawomen
AT yiweyshieh wholeexomesequencingidentifiesfancmasasusceptibilitygeneforestrogenreceptornegativebreastcancerinhispaniclatinawomen
AT laurafejerman wholeexomesequencingidentifiesfancmasasusceptibilitygeneforestrogenreceptornegativebreastcancerinhispaniclatinawomen
AT stephenbgruber wholeexomesequencingidentifiesfancmasasusceptibilitygeneforestrogenreceptornegativebreastcancerinhispaniclatinawomen
AT christopherahaiman wholeexomesequencingidentifiesfancmasasusceptibilitygeneforestrogenreceptornegativebreastcancerinhispaniclatinawomen
AT esthermjohn wholeexomesequencingidentifiesfancmasasusceptibilitygeneforestrogenreceptornegativebreastcancerinhispaniclatinawomen
AT lawrencehkushi wholeexomesequencingidentifiesfancmasasusceptibilitygeneforestrogenreceptornegativebreastcancerinhispaniclatinawomen
AT gabrielatorresmejia wholeexomesequencingidentifiesfancmasasusceptibilitygeneforestrogenreceptornegativebreastcancerinhispaniclatinawomen
AT charitericker wholeexomesequencingidentifiesfancmasasusceptibilitygeneforestrogenreceptornegativebreastcancerinhispaniclatinawomen
AT jeffreynweitzel wholeexomesequencingidentifiesfancmasasusceptibilitygeneforestrogenreceptornegativebreastcancerinhispaniclatinawomen
AT eladziv wholeexomesequencingidentifiesfancmasasusceptibilitygeneforestrogenreceptornegativebreastcancerinhispaniclatinawomen
AT susanlneuhausen wholeexomesequencingidentifiesfancmasasusceptibilitygeneforestrogenreceptornegativebreastcancerinhispaniclatinawomen